Analysts' Consensus ; Mean consensus. BUY ; Number of Analysts. 3 ; Last Close Price. USD ; Average target price. USD ; Spread / Average Target. +%. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock's expected. Earnings for Citius Pharmaceuticals are expected to grow in the coming year, from ($) to $ per share. Price to Earnings Ratio vs. the Market. The P/E. Citius Pharmaceuticals (CTXR) stock price prediction is USD. The Citius Pharmaceuticals stock forecast is USD for Citius Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CTXR updated stock price target summary.
Future criteria checks 5/6 · Key information · Recent future growth updates · Price target increased by 22% to US$ · Forecast breakeven date pushed back to The 2 analysts with month price forecasts for CTXR stock have an average target of , with a low estimate of and a high estimate of Analyst Price Targets. Average. Current. High. View More. Company Insights: CTXR. CTXR does not have Company Insights. People Also Watch. CITIUS PHARMACEUTICALS INC (CTXR) Price Targets From Analysts ; , 2, $10, $4, $7 ; , 3, $10, $4, $6. This is based on calculating the average month share price estimate provided by 1 stock analysts who have covered CTXR. Price targets range from $4 at the. View Citius Pharmaceuticals Inc CTXR stock quote prices, financial information, real-time forecasts, and company news from CNN. According to analysts, CTXR price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. Citius Pharmaceuticals Inc Stock (CTXR) is expected to reach an average price of $ in , with a high forecast of $ and a low forecast of $0. future price: according to them, CTXR price has a max estimate of USD and a min estimate of USD. Watch CTXR chart and read a more detailed Citius. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Citius Pharmaceuticals Analyst Opinions. All.
The average one-year price target for Citius Pharmaceuticals, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ CTXR will report FY earnings on 11/27/ Yearly Estimates. According to 2 Wall Street analysts that have issued a 1 year CTXR price target, the average CTXR price target is $, with the highest CTXR stock price. According to 2 analysts, the average rating for CTXR stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from the. Citius Pharmaceuticals started at buy with $4 stock price target at Maxim Group. Nov. 30, at a.m. ET by Tomi Kilgore. Citius stock price target. Citius Pharmaceuticals Stock Forecast, CTXR stock price prediction. Price target in 14 days: USD. The best long-term & short-term Citius. Citius Pharmaceuticals Stock Smart Score ; Analyst Consensus. Moderate Buy. Average Price Target: $ (% Upside) ; Hedge Fund Trend. Decreased. By K. The forecasts for Citius Pharmaceuticals, Inc. (CTXR) range from a low of $4 to a high of $6. The average price target represents a increase of $ from the. Citius Pharmaceuticals Inc has a consensus price target of $ based on the ratings of 3 analysts. The high is $6 issued by EF Hutton on August 19,
Assess the Citius Pharma stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst Month. The average one-year price target for Citius Pharmaceuticals, Inc. is $ The forecasts range from a low of $ to a high of $ Citius Pharmaceuticals, Inc. (CTXR) stock forecast and price target · CTXRCitius Pharmaceuticals, Inc. (%). At close: August 22 PM. The average stock forecast for Citius Pharmaceuticals Inc (CTXR) is USD. This price target corresponds to an upside of %. CTXR's current price target is $ Learn why top analysts are making this stock forecast for Citius Pharmaceuticals at MarketBeat.
Top Pharma Stocks to Watch Now - BioPharma Stock News Today - Citius Pharmaceuticals - CTXR
Analyst. Target Price. · 3 analysts ; Earnings. EPS Estimate. -. Due Feb 15 ; Investor. New Investor. Susquehanna International Group. The Citius Pharmaceuticals Inc stock price today is What Is the Stock Symbol for Citius Pharmaceuticals Inc? The stock ticker symbol for Citius. Stock price target for Citius Pharmaceuticals, Inc. CTXR are on downside and on upside. Stock price target for Citius Pharmaceuticals, Inc. CTXR. Get Wall Street analysts ratings for Citius Pharmaceuticals, Inc. (CTXR). Buy or Sell this stock? See what the analysts say. CTXR Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Makes less than USD$1m in revenue ($0). If the Company does not regain compliance with the Bid Price Rule by September 9, , Nasdaq will provide written notice to us that our common stock is. Track Citius Pharmaceuticals Inc (CTXR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Get the latest Citius Pharmaceuticals (CTXR) stock forecast for tomorrow and next week. Stay ahead of the game with our Citius Pharmaceuticals stock price.
Best Credit Cards To Apply For 2021 | What Is 11 At T On My Credit Report